Skip to main content

Vyant Bio, Inc.

VYNTDelisted May 4, 2023
Industry
Services-Medical Laboratories
SEC CIK
0001349929

Vyant Bio, Inc. was delisted on May 4, 2023; its insiders filed their last Form 4 on Feb 27, 2023; 17 institutions reported holding it in 13F filings for Q1 2023, worth $136.8K in total; no superinvestor held it.

Holders of 5% or more of VYNT

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Vyant Bio, Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Vyant Bio, Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

13 Schedule 13D and 13G filings on Vyant Bio, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on VYNT
Filed (ET)FilerFormStakeChangeEvent dateFiling
Feb 14, 2023FOD Capital, LLC13G/AOld format–––SEC
Feb 14, 2022FOD Capital, LLC13GOld format–New–SEC
Feb 11, 2022Intracoastal Capital, LLC13G/AOld format–––SEC
Feb 11, 2022Renaissance Technologies LLC13G/AOld format–––SEC
Feb 9, 2022Lind Global Macro Fund LP13G/AOld format–––SEC
Feb 7, 2022Bigger Capital Fund L P13G/AOld format–––SEC
Feb 25, 2021FiveT Investment Management Ltd13DOld format–New–SEC
Feb 11, 2021Ionic Ventures, LLC13G/AOld format–––SEC
Feb 11, 2021Renaissance Technologies LLC13G/AOld format–––SEC
Feb 9, 2021Intracoastal Capital, LLC13GOld format–New–SEC
Feb 8, 2021Bigger Capital Fund L P13GOld format–New–SEC
Feb 3, 2021Lind Global Macro Fund LP13GOld format–New–SEC
Jan 14, 2021Alpha Capital Anstalt13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Vyant Bio, Inc. shares.

No Form 144 notices for Vyant Bio, Inc. are on file.